134 related articles for article (PubMed ID: 11717339)
1. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
Goffin J; Chappuis PO; Wong N; Foulkes WD
J Natl Cancer Inst; 2001 Nov; 93(22):1754-5. PubMed ID: 11717339
[No Abstract] [Full Text] [Related]
2. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
3. MRI surveillance for hereditary breast-cancer risk.
Warner E; Causer PA
Lancet; 2005 May 21-27; 365(9473):1747-9. PubMed ID: 15910935
[No Abstract] [Full Text] [Related]
4. Clinical practice. Management of an inherited predisposition to breast cancer.
Robson M; Offit K
N Engl J Med; 2007 Jul; 357(2):154-62. PubMed ID: 17625127
[No Abstract] [Full Text] [Related]
5. The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations.
Macklin S; Gass J; Mitri G; Atwal PS; Hines S
Fam Cancer; 2018 Jan; 17(1):167-173. PubMed ID: 28643015
[TBL] [Abstract][Full Text] [Related]
6. Screening for breast cancer in women at moderate and high risk.
Gilbert FJ
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):240-3. PubMed ID: 15997918
[No Abstract] [Full Text] [Related]
7. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
[TBL] [Abstract][Full Text] [Related]
9. The case for individualized screening recommendations for breast cancer.
Bradbury A; Olopade OI
J Clin Oncol; 2006 Jul; 24(21):3328-30. PubMed ID: 16801629
[No Abstract] [Full Text] [Related]
10. What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
Trecate G; Agresti R; Suman L; Vergnaghi D; Valeri B; Marchesini M; Ferranti C; Ferraris C; Manoukian S; Scaperrotta G; Viganò S; Panizza P
Eur J Radiol; 2012 Sep; 81 Suppl 1():S165-70. PubMed ID: 23083576
[No Abstract] [Full Text] [Related]
11. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
Warner E; Plewes DB; Shumak RS; Catzavelos GC; Di Prospero LS; Yaffe MJ; Goel V; Ramsay E; Chart PL; Cole DE; Taylor GA; Cutrara M; Samuels TH; Murphy JP; Murphy JM; Narod SA
J Clin Oncol; 2001 Aug; 19(15):3524-31. PubMed ID: 11481359
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.
Walsh EM; Farrell MP; Nolan C; Gallagher F; Clarke R; McCaffrey JA; Kennedy MJ; Barry M; Kell MR; Gallagher DJ
Ir J Med Sci; 2016 Feb; 185(1):189-94. PubMed ID: 25673166
[TBL] [Abstract][Full Text] [Related]
13. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
Leach MO; Boggis CR; Dixon AK; Easton DF; Eeles RA; Evans DG; Gilbert FJ; Griebsch I; Hoff RJ; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Thompson D; Warren RM;
Lancet; 2005 May 21-27; 365(9473):1769-78. PubMed ID: 15910949
[TBL] [Abstract][Full Text] [Related]
14. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Rijnsburger AJ; Obdeijn IM; Kaas R; Tilanus-Linthorst MM; Boetes C; Loo CE; Wasser MN; Bergers E; Kok T; Muller SH; Peterse H; Tollenaar RA; Hoogerbrugge N; Meijer S; Bartels CC; Seynaeve C; Hooning MJ; Kriege M; Schmitz PI; Oosterwijk JC; de Koning HJ; Rutgers EJ; Klijn JG
J Clin Oncol; 2010 Dec; 28(36):5265-73. PubMed ID: 21079137
[TBL] [Abstract][Full Text] [Related]
15. Breast MR imaging screening in eight women proved or suspected to be carriers of BRCA1&2 gene mutations.
Cilotti A; Caligo MA; Cipollini G; Francesca D; Marini C; Moretti M; Roncella M; Bartolozzi C; Bevilacqua G
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):137-40. PubMed ID: 12585668
[TBL] [Abstract][Full Text] [Related]
16. Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer.
Liljegren A; von Wachenfeldt A; Azavedo E; Eloranta S; Grundström H; Ståhlbom AK; Sundbom A; Sundén P; Svane G; Ulitzsch D; Arver B
Breast Cancer Res Treat; 2018 Apr; 168(3):655-666. PubMed ID: 29318406
[TBL] [Abstract][Full Text] [Related]
17. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).
Leach MO; Eeles RA; Turnbull LW; Dixon AK; Brown J; Hoff RJ; Coulthard A; Dixon JM; Easton DF; Evans DG; Gilbert FJ; Hawnaur J; Hayes C; Kessar P; Lakhani S; Liney G; Moss SM; Padhani AP; Pointon LJ; Sydenham M; Walker LG; Warren RM; Haites NE; Morrison P; Cole T; Rayter Z; Donaldson A; Shere M; Rankin J; Goudie D; Steel CM; Davidson R; Chu C; Ellis I; Mackay J; Hodgson SV; Homfray T; Douglas F; Quarrell OW; Eccles DM; Gilbert FG; Crothers G; Walker CP; Jones A; Slack N; Britton P; Sheppard DG; Walsh J; Whitehouse G; Teh W; Rankin S; Boggis C; Potterton J; McLean L; Gordon PA; Rubin C;
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):107-14. PubMed ID: 12585664
[TBL] [Abstract][Full Text] [Related]
18. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.
Foulkes WD
Clin Genet; 2014 Jan; 85(1):1-4. PubMed ID: 24116874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
